The medical AI hierarchical diagnosis and treatment system will be fully implemented

During the National Two Sessions in 2022, issues related to the digital economy and ensuring the improvement of medical and health service capabilities have become social hots pots. At the same time, the “Government Work Report” also clearly mentioned that the top priority of the government’s work this year is to improve medical and health service capabilities and health services. The ability to prevent and treat diseases at the grassroots level.

Under the policy guidance issued by the government, 2022 will undoubtedly be the year for the development of the AI industry. In the context of clearly promoting digital transformation and developing smart cities and digital villages, medical AI will usher in new opportunities for development and comprehensively promote industrial development. , to clear the obstacles to the commercialization of AI.

As the “first medical AI stock” listed on the Hong Kong stock market at the end of last year, Eagle Eye Technology has unique hardware equipment in the detection and diagnosis of medical device software. Take Airdoc AIFUNDUS as an example, it can use AI to analyze retinal images and other data to help Doctors can accurately detect and assist in diagnosing chronic diseases. The retina is the only place in the human body that can non-invasively and directly observe blood vessels and nerves. Through the lesions of blood vessels and nerves on the retina, more than 200 kinds of diabetes, hypertension, myocardial infarction, stroke, etc. can be judged Common chronic diseases, the birth of retinal imaging AI products has greatly promoted the development of the medical AI industry in the prevention and control of chronic diseases.

Globally, the number of deaths from cardiovascular and cerebrovascular diseases has far exceeded that of tumor patients. Compared with blood testing, it is easier to observe subtle changes in human blood vessels through the retina. The research and use of retinal imaging AI products is the first attempt in my country to combine artificial Intelligent technology and fundus photo information predict the risk of cardiovascular and cerebrovascular diseases in Chinese people. Through AI assistance, health risks can be well monitored, chronic diseases such as cardiovascular and cerebrovascular diseases can be intervened, and the efficiency of doctors’ diagnosis and treatment can be improved.

Through the combination of fundus camera + AI intelligent software, the improvement of AI technology and computing power will continue to increase. It is expected that by 2030, China’s AI theory, technology and application will generally reach the world’s leading level, and it is expected to reduce the cost of use through technological innovation. Increase the size of the market so that more grassroots hospitals can use it, and more grassroots people can enjoy AI medical services, and effectively promote and improve my country’s tiered diagnosis and treatment system. It is believed that with the continuous development of the digital economy, AI medical services will enter our lives with better health care services, making AI medical services ubiquitous.